‘Smart drug’ shows promise for metastatic triple-negative breast cancer
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
List view / Grid view
News
Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
Structural barriers biggest reason for low participation in clinical trials
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
Inadequate FDA oversight concerning fentanyl prescriptions
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
Oral antifungals used to treat yeast infections could lead to miscarriage
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
Drug combination may become new standard treatment for advanced kidney cancer
Immunotherapy drug plus targeted agent provided better progression-free survival and shrank tumors in more patients than standard one-drug treatment...
Perigord announces the release of GLAMS CMO
Simplify your artwork process, get closer to your customers and strengthen compliance...
Biotech firm awarded for approach to drug development
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...
Policy to improve access and foster price competition for generics
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
Phase III combination trial improves survival in men with metastatic prostate cancer
A Phase III clinical trial has shown that metastatic prostate cancer improved through the use of a combination therapy with enzalutamide...
No association between antiepileptic drug use and dementia
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
Advancing the application of artificial intelligence to health
A collaboration between Brigham and Women's Hospital and Vanderbilt University Medical Center looks to advance the application of AI in health...
Draft guidance on CDER’s program to recognise standards in pharmaceutical quality
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
Programs to promote innovations in drug manufacturing
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
SMC accepts restricted use of rivaroxaban for CAD
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
